In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Coffee Chat: Mike Carmody, Advanced Diabetes Supply
Carmody explains how integrating Cardinal Health, CGMs, and changes to Medicare rules are transforming diabetes care and pharmacy workflows.
Coffee Chat: Rebecca Brown, E.T. Browne
Rebecca Brown, VP of marketing at E.T. Browne, explains how Palmer’s combines heritage, innovation, and digital engagement to offer indulgent yet accessible self-care experiences.
Latest
Ulta Beauty tops Wall Street expectations for third quarter
Beauty retailer raises its full-year outlook.
Focal Systems addresses grocery shrink
Theft Spotter alerts food retailers when specific items are stolen.
San Francisco files landmark lawsuit against ultra-processed food giants
The suit, filed in California Superior Court, names Kraft Heinz, Mondelez, Post, Coca-Cola, PepsiCo, General Mills, Nestlé, Kellanova, Kellogg, Mars, and ConAgra
Kroger delivers solid quarter despite $2.6 billion impairment
Gains in eCommerce and private-label brands offset charges tied to automated fulfillment network; grocer lifts earnings guidance for the year